PR-Section 8 and 9

PTO Form 1963 (Rev 5/2006)

OMB No. 0651-0055 (Exp 07/31/2018)

---

PTO Form 1963 (Rev 5/2006)

OMB No. 0651-0055 (Exp 07/31/2018)

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9

To the Commissioner for Trademarks:

REGISTRATION NUMBER: 2727955
REGISTRATION DATE: 06/17/2003

MARK: ERRIN

The owner, Barr Laboratories, Inc., a corporation of New Jersey, having an address of
      400 Chestnut Ridge Road
      Woodcliff Lake, New Jersey 07677
      United States
is filing a Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9.

For International Class 005, the mark is in use in commerce on or in connection with all goods/services, or to indicate membership in the collective membership organization, listed in the existing registration for this specific class: Pharmaceutical preparations, namely, oral contraceptives ; or, the owner is making the listed excusable nonuse claim.

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) Image of the product as sold in the market.
Specimen File1
The registrant's current Correspondence Information: HERSCHEL PEREL of  TEVA PHARMACEUTICALS USA
      425 PRIVET ROAD
      TRADEMARKS DEPARTMENT
      HORSHAM, Pennsylvania (PA) 19044
      United States


The registrant's proposed Correspondence Information: HERSCHEL PEREL of  Teva Pharmaceutical USA
      Trademarks Department
      425 Privet Road
      HORSHAM, Pennsylvania (PA) 19044
      United States



The phone number is 215-293-6406.

The fax number is 215-293-6499.

The email address is herschel.perel@tevapharm.com.

The registrant hereby appoints Herschel Perel, Trademarks Department, 425 Privet Road, Horsham, Pennsylvania (PA) United States (USX) 19044 as registrant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The phone number is 2152936406.

The fax number is 215-293-6499.

The email address is herschel.perel@tevapharm.com.

A fee payment in the amount of $500 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.

Declaration


Section 8: Declaration of Use and/or Excusable Nonuse in Commerce
Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods and/or services identified above, as evidenced by the attached specimen(s) showing the mark as used in commerce.


The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.

Section 9: Application for Renewal
The registrant requests that the registration be renewed for the goods/services/collective organization identified above.


Signature: /herschel perel/      Date: 05/01/2013
Signatory's Name: Herschel Perel
Signatory's Position: Senior Director
Signatory's Phone Number: 215-293-6406

Serial Number: 76317691
Internet Transmission Date: Wed May 01 11:33:27 EDT 2013
TEAS Stamp: USPTO/S08N09-XX.XXX.XXX.X-20130501113327
700120-2727955-500cab8cbe5e1a8cac8f3bd6d
275f539d13df43c0b929cab3bba2487921b08e7a
-DA-10474-20130501111843820790